Rasmus Holm-Jorgensen

Chief Financial Officer, Acrivon Therapeutics, Inc.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Feb 14, 2025Shares withheld for tax 434 shares at $5.42 of Acrivon Therapeutics, Inc.²
Nov 14, 2024Shares withheld for tax 368 shares at $7.92 of Acrivon Therapeutics, Inc.³
Aug 14, 2024Shares withheld for tax 368 shares at $7.02 of Acrivon Therapeutics, Inc.⁴
May 14, 2024Shares withheld for tax 368 shares at $8.36 of Acrivon Therapeutics, Inc.⁵
Feb 14, 2024Shares withheld for tax 434 shares at $3.40 of Acrivon Therapeutics, Inc.⁶
Nov 14, 2023Shares withheld for tax 1,470 shares at $5.08 of Acrivon Therapeutics, Inc.⁷
Jun 16, 2023Exercised options 9,500 shares at $3.63 of Acrivon Therapeutics, Inc.⁸
Nov 14, 2022Granted 20,030 shares of Acrivon Therapeutics, Inc.⁹

The numbers on this page point here. Each one links to the record it came from.